Engeler D, Baranowski A, Borovicka J. EAU guidelines on chronic pelvic pain. Copenhagen: EAU Guidelines. in EAU Annual Congress; 2018.

Google Scholar 

Hanno PM, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545–53.

Article  PubMed  Google Scholar 

Engeler DS, et al. The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol. 2013;64(3):431–9.

Article  PubMed  Google Scholar 

Bogart LM, et al. Prevalence and correlates of sexual dysfunction among women with bladder pain syndrome/interstitial cystitis. Urology. 2011;77(3):576–80.

Article  PubMed  Google Scholar 

Giannantoni A, et al. Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol. 2008;179(3):1031–4.

Article  CAS  PubMed  Google Scholar 

Sacco E, et al. Bladder pain syndrome associated with highest impact on sexual function among women with lower urinary tract symptoms. Int J Gynaecol Obstet. 2012;117(2):168–72.

Article  PubMed  Google Scholar 

Okui N, Okui M, Gambacciani M. Examining vaginal and vulvar health and sexual dysfunction in patients with interstitial cystitis (UNICORN-1 study). Int Urogynecol J. 2022;33(9):2493–9.

Article  PubMed  Google Scholar 

Gupta P, et al. A multidisciplinary approach to the evaluation and management of interstitial cystitis/bladder pain syndrome: an ideal model of care. Transl Androl Urol. 2015;4(6):611–9.

PubMed  PubMed Central  Google Scholar 

Peters KM, et al. Sexual function and sexual distress in women with interstitial cystitis: a case-control study. Urology. 2007;70(3):543–7.

Article  PubMed  Google Scholar 

Carrico DJ, Sherer KL, Peters KM. The relationship of interstitial cystitis/painful bladder syndrome to vulvodynia. Urol Nurs. 2009;29(4):233–8.

PubMed  Google Scholar 

Dykstra DD, et al. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol. 1988;139(5):919–22.

Article  CAS  PubMed  Google Scholar 

Schurch B, et al. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164(3 Pt 1):692–7.

Article  CAS  PubMed  Google Scholar 

Schulte-Baukloh H, et al. Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology. 2005;66(1):82–7.

Article  PubMed  Google Scholar 

Smith CP, et al. Botulinum toxin a has antinociceptive effects in treating interstitial cystitis. Urology. 2004;64(5):871–5 (discussion 875).

Article  PubMed  Google Scholar 

Zhang W, et al. Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis. Int Urogynecol J. 2017;28(4):515–25.

Article  PubMed  Google Scholar 

Brown EA, Schütz SG, Simpson DM. Botulinum toxin for neuropathic pain and spasticity: an overview. Pain Manag. 2014;4(2):129–51.

Article  PubMed  Google Scholar 

Park J, Park HJ. Botulinum toxin for the treatment of neuropathic pain. Toxins (Basel). 2017;9(9):260.

Article  PubMed  Google Scholar 

Lagueny A, Burbaud P. Mechanism of action, clinical indication and results of treatment of botulinum toxin. Neurophysiol Clin. 1996;26(4):216–26.

Article  CAS  PubMed  Google Scholar 

Chen JL, Kuo HC. Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis. Investig Clin Urol. 2020;61(Suppl 1):S33-s42.

Article  PubMed  Google Scholar 

Lucioni A, et al. Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 2008;101(3):366–70.

Article  CAS  PubMed  Google Scholar 

Yiangou Y, et al. Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int. 2001;87(9):774–9.

Article  CAS  PubMed  Google Scholar 

Guo BL, et al. A closer look to botulinum neurotoxin type A-induced analgesia. Toxicon. 2013;71:134–9.

Article  CAS  PubMed  Google Scholar 

Chiu B, et al. Botulinum toxin A for bladder pain syndrome/interstitial cystitis. Toxins (Basel). 2016;8(7):201.

Article  PubMed  Google Scholar 

Sengupta JN. Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol. 2009;194:31–74.

Article  CAS  Google Scholar 

Jhang JF. Using botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome-possible pathomechanisms and practical issues. Toxins (Basel). 2019;11(11):641.

Article  CAS  PubMed  Google Scholar 

Jhang JF, Kuo HC. Novel applications of onabotulinum toxin A in lower urinary tract dysfunction. Toxins (Basel). 2018;10(7):260.

Article  PubMed  Google Scholar 

Yosef A, et al. Multifactorial contributors to the severity of chronic pelvic pain in women. Am J Obstet Gynecol. 2016;215(6):760.e1-760.e14.

Article  PubMed  Google Scholar 

Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008;9(6):453–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Jiang YH, et al. Comparative study of efficacy and safety between bladder body and trigonal intravesical onabotulinum toxin A injection in the treatment of interstitial cystitis refractory to conventional treatment-a prospective, randomized, clinical trial. Neurourol Urodyn. 2018;37(4):1467–73. This trial compared the injection locations.

Article  CAS  PubMed  Google Scholar 

•• Evans RJ, et al. Injection location does not impact botulinum toxin A efficacy in interstitial cystitis/bladder pain syndrome patients. Can J Urol. 2020;27(1):10125–9. This trial compared the injection locations.

PubMed  Google Scholar 

•• Pinto RA, et al. Intratrigonal onabotulinum toxin A improves bladder symptoms and quality of life in patients with bladder pain syndrome/interstitial cystitis: a pilot, single center, randomized, double-blind, placebo controlled trial. J Urol. 2018;199(4):998–1003. This trial showed the efficacy of trigonal injections.

Article  CAS  PubMed  Google Scholar 

Jhang JF, Kuo HC. Novel applications of non-invasive intravesical botulinum toxin a delivery in the treatment of functional bladder disorders. Toxins (Basel). 2021;13(5):359.

Article  CAS  PubMed  Google Scholar 

Chuang YC, Kuo HC. A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinum toxin A for interstitial cystitis/bladder pain syndrome. J Urol. 2017;198(2):376–82.

Article  CAS  PubMed  Google Scholar 

Rappaport YH, et al. Safety and feasibility of intravesical instillation of botulinum toxin-A in hydrogel-based slow-release delivery system in patients with interstitial cystitis-bladder pain syndrome: a pilot study. Urology. 2018;114:60–5.

Article  PubMed  Google Scholar 

Kopecek J. Hydrogel biomaterials: a smart future? Biomaterials. 2007;28(34):5185–92.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang YH, et al. Low-energy shock wave plus intravesical instillation of botulinum toxin A for interstitial cystitis/bladder pain syndrome: pathophysiology and preliminary result of a novel minimally invasive treatment. Biomedicines. 2022;10(2):396.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Chen A, Shahiyan RH, Anger JT. Interstitial cystitis/bladder pain syndrome treatment: a systematic review of sexual health outcomes. Sex Med Rev. 2022;10(1):71–6. This review focused on the sexual health outcomes of Interstitial cystitis/Bladder pain syndrome.

Article  PubMed  Google Scholar 

•• Topcuoglu M, et al. Sexual dysfunction in women with interstitial cystitis/bladder pain syndrome: do onabotulinum toxin-A injections improve sexual function? Neurourol Urodyn. 2023;42(3):607–14. This is the first study investigating BoNT-A effects on sexual functions in patients with IC/BPS.

Article  CAS  PubMed  Google Scholar 

Balzarro M, et al. Onabotulinum toxin A detrusor injection improves female sexual function in women with overactive bladder wet syndrome. Eur J Obstet Gynecol Reprod Biol. 2018;225:228–31.

Article  CAS  PubMed  Google Scholar 

Shawer S, et al. Impact of intravesical onabotulinum toxin A (Botox) on sexual function in patients with overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2022;33(2):235–43.

PubMed  Google Scholar